Virginia Tancioco, MD, MBA, Boston University

Early pregnancy loss (EPL) is defined as a nonviable, intrauterine pregnancy prior to 13 weeks of gestation. In the United States, there are about 1 million EPLs per year. In the ED setting, treating EPL can be challenging. ED physicians normally recommend Obstetrics and Gynecology (Ob/Gyn) outpatient or inpatient consult often leading to a delay ...Read more >

Alexandra Monaco, MD, Columbia University

During the COVID-19 pandemic, video visits have been more widely used for contraceptive counseling. Patient satisfaction with video visits for contraceptive counseling has not yet been evaluated. A patient-reported outcome measure (PRO-PM) was developed to evaluate the interpersonal quality of contraceptive counseling (Dehlendorf 2018). This will be an exploratory survey with the primary outcome being ...Read more >

Ashley Navarro, MD, MPH, University of North Carolina Hospitals at Chapel Hill

Public health disasters lead institutional medical priorities away from family planning services. Reproductive health suffers when healthcare systems are not prepared for public health or natural disasters. The objective of this study is to investigate the knowledge, attitudes, and practices of sexual and reproductive health providers of in the US during the time of the ...Read more >

June Ng, MD, Albert Einstein College of Medicine

In 1980, China implemented a one-child policy to curb population growth they believed would stifle the standard of living in the aftermath of the Cultural Revolution. This was implemented through mandatory intrauterine devices for women with one child, abortion for “unauthorized ” pregnancies, and permanent contraception for couples with two or more children. A lack ...Read more >

Marit Pearlman Shapiro, MD, MPH, University of Hawaii

Hemorrhage is the most common complication of dilation and evacuation (D&E). Prophylactic tranexamic acid has shown been shown to reduce maternal mortality from postpartum hemorrhage with no adverse effects, but has not been studied to reduce bleeding complications with D&E. We propose a randomized, double-blinded, placebo-controlled pilot study to determine whether routine use of intravenous ...Read more >

Charita Roque, MD, MPH, Johns Hopkins University

Racial inequities in maternal health, although present over centuries, have worsened in the last several decades. Despite growing interest in racial disparities in maternal health, little research has examined disparities in abortion practice specifically. One of the challenges of tracking abortion complications is the overall low complication rate. Cited complication rates of surgical abortions range ...Read more >

Katrina Heyrana, MD, PhD, University of Southern California

Sexual and reproductive health (SRH) research commonly combines Asians into one entity. However, subgroup-specific interactions between cultural/religious values, health beliefs, and acculturation lead to different SRH utilization patterns and outcomes. For example, Filipinos experience some of the highest rates of adolescent pregnancy and severe maternal morbidity among Asian subgroups. Disaggregating Asian health data is therefore ...Read more >

Alison Lutz, MD, University of Michigan

Dilation and evacuation (D&E) is the safest and most common method of second trimester abortion. D&E’s safety depends largely on sufficient cervical preparation which traditionally has been done with osmotic dilation. Adequate dilation can be achieved quickly with Dilapan-S allowing for same day procedures, even in the mid-second trimester. Recently, however, the cost of Dilapan-S ...Read more >

Rithika Mathias, MD, Albert Einstein College of Medicine

Housing insecurity continues to be a pervasive issue throughout the United States, with numbers projected to increase due to the Covid-19 pandemic. Families in particular continue to be a growing segment of the homeless population. In New York City women are the “head of the household” in ninety-three percent of homeless families. Research shows homeless ...Read more >

Hillary McLaren, MD, University of Chicago

The HPV vaccine has the ability to eradicate cervical cancer, but many people are making it to adulthood without completing the recommended vaccine series. A focus of public health efforts has been to vaccinate these patients when they interface with the healthcare system. We recognize the abortion visit as such a time. Education and a ...Read more >